NEXT
Sign in to follow

The Legal Intelligencer

J&J Hit With $20M Verdict in Third Pelvic Mesh Trial

A 12-member Philadelphia jury handed up a $20 million verdict—including $17.5 million in punitive damages—against Johnson & Johnson subsidiary Ethicon in the third pelvic mesh case to go to trial in the city.
4 minute read

Litigation Daily

Litigator of the Week: Going for the Jugular in Blood Thinner Bellwether

A federal jury in New Orleans deliberated for less than two hours before coming back this week with a defense win in the first bellwether trial over the blood thinner Xarelto. That's a bona fide slam dunk--even for lead defense counsel Beth Wilkinson, who's notched a streak of trial victories in her career.
11 minute read

New York Law Journal

Split Panel Allows NYU Suit Against Pfizer to Proceed

New York University's breach of contract lawsuit against Pfizer over hundreds of millions of dollars in cancer drug royalties must go forward, a divided Manhattan appeals court has ruled.
2 minute read

New Jersey Law Journal

Drugmakers Face Suits Linking Diabetes Med to Heart Failure

AstraZeneca Pharmaceuticals and Bristol-Myers Squibb were hit with 14 suits in the District of New Jersey on Tuesday claiming that users of diabetes drug saxagliptin face elevated risks of heart failure as a result of using the drug.
3 minute read

National Law Journal

J&J Fends Off Xarelto Claims in First Bellwether Trial

Johnson & Johnson subsidiary Janssen Pharmaceuticals Inc. and Bayer brought in powerhouse litigator Beth Wilkinson of Washington, D.C.'s Wilkinson Walsh + Eskovitz to lead the defense team in the first of four bellwether trials.
4 minute read

New Jersey Law Journal

$25M Accutane Verdict Tossed Over Expert TestimonyLimits

A state appeals court tossed a $25 million verdict against Hoffmann-La Roche in a suit over acne drug Accutane after finding that the trial judge improperly restricted duplicative testimony from two defense experts.
11 minute read

The Legal Intelligencer

485 Pharmacies Sue Catamaran Successor Over Reimbursements

A group of 485 independently owned pharmacies nationwide has sued OptumRx, the successor company to Catamaran Corp. through a merger, claiming they were low-balled on reimbursements based on outdated pricing data.
2 minute read

The Legal Intelligencer

Expert Witness' Move to Aid Stricken Juror Leads to Risperdal Post-Trial Motion

Three weeks before the latest Risperdal case was tossed out midtrial, one of the jurors initially tasked with evaluating the claims collapsed while a plaintiff's expert was testifying on the stand.
8 minute read

National Law Journal

Appellate Court Won't Overhaul 'On-Sale' Patent Bar

The U.S. Court of Appeals for the Federal Circuit ruled a drug used to treat chemotherapy symptoms did not avoid the on-sale bar for patents despite keeping some details of its drug sale confidential.
3 minute read

New York Law Journal

US Judge Sanctions Milberg for Actions in Qui Tam Case

A federal judge in Massachusetts ruled Manhattan plaintiffs firm Milberg "implemented an elaborate scheme of misrepresentation and deceit under the guise of a legitimate medical research study" and dismissed a plaintiff's qui tam action.
14 minute read

TRENDING STORIES

Law Pro Logo

Featured Firms

Law Offices of Gary Martin Hays & Associates, P.C.

(470) 294-1674

Law Offices of Mark E. Salomone

(857) 444-6468

Smith & Hassler

(713) 739-1250

More from ALM

More from ALM

Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

Resources

  • Leveraging Technology to Improve Employee Engagement and Client Satisfaction

    Brought to you by CARET Legal

    Download Now

  • How to Choose Your Legal Operations Software: Key Considerations and Expert Tips

    Brought to you by DiliTrust

    Download Now

  • Yearly Roundup: Strategic Insights for Law Firm Decision Making

    Brought to you by CARET Legal

    Download Now

  • Lex Machina Contracts: Commercial Litigation Report 2024

    Brought to you by LexisNexis®

    Download Now